We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Res.Phm.Reg S | LSE:RPSE | London | Ordinary Share | COM SHS USD0.0001(REG S) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:6452N
Research Pharmaceutical SRV, Inc
11 February 2008
11 February 2008
ReSearch Pharmaceutical Services, Inc.
Company presentation
ReSearch Pharmaceutical Services, Inc. (the "Company") advises that it is today
presenting at the UBS Global Healthcare Services Conference.
No material new information will be disclosed in the presentation and there will
be no further statement on the performance of the Company beyond the 3rd quarter
results statement of 14 December 2007.
The presentation will be available later today from the Company's website,
www.rpsweb.com.
Enquires:
ReSearch Pharmaceutical Services, Inc.: +1-215-540-0700
Daniel M. Perlman, Chairman & Chief Executive Officer
Steven Bell, Chief Financial Officer
Nominated Adviser and UK Broker: +44-20-7012-2000
Arbuthnot Securities Limited
James Steel/Richard Tulloch
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCZVLFBVLBFBBX
1 Year Res.Phm.Reg S Chart |
1 Month Res.Phm.Reg S Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
